Patients with multiple myeloma often develop bone lesions resulting in skeletal-related events (SREs), such as spinal cord compression, vertebral collapse, pathologic fractures and bone pain. Bone ...

Topline data were announced from a phase 3 trial evaluating garetosmab in adults with fibrodysplasia ossificans progressiva.

Please provide your email address to receive an email when new articles are posted on . Bone marrow lesions can decrease local progenitor cells, reducing the ability to heal. Types of bone marrow ...

Firm foot orthoses show superior efficacy in reducing midfoot pain and bone marrow lesion volume at 12 weeks compared with ...

The team tackled a critical challenge in treating multiple myeloma-a blood cancer where malignant plasma cells accumulate in bone marrow, leading to debilitating bone lesions in 80% of patients. These ...

A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings showcase a ...

Investing.com -- Regeneron ’s Phase 3 Optima trial of garetosmab in adults with fibrodysplasia ossificans progressiva (FOP) has successfully met its primary endpoint, demonstrating significant ...

Tito Aureliano et al./The Anatomical Record Fossils from Brazil reveal sauropods plagued by a painful bone disease that ...